In preeclampsia, the most severe form of pregnancy-induced hypertension, studies have consistently found alterations in calcium and vitamin D metabolism during clinical disease in late pregnancy; these include hypocalciuria 4 -7 and low serum 1,25-dihydroxyvitamin D (1,25(OH) 2 D). 8 -11 A recent nested case-control study reported lower early pregnancy levels of 25(OH)D in women who later developed preeclampsia, suggesting that 25(OH)D deficiency antedates disease onset and might contribute to its pathogenesis. 12 According to the "free hormone hypothesis," only hormones liberated from binding proteins are able to enter cells to perform biological actions. 13 Vitamin D binding protein (VDBP), abundant in the circulation, serves as the major binding protein for 25(OH)D and 1,25(OH) 2 D. Circulating vitamin D of both forms is almost entirely bound to albumin (10% to 15%) and VDBP (85% to 90%), 14,15 which act as vitamin D reservoirs and slow its metabolism. 16 VDBP increases in high-estrogen states, such as pregnancy. 17, 18 Because measurement of total 25(OH)D is necessarily a measurement of the vitamin D/VDBP complex, alterations in VDBP levels in preeclamptic pregnancy could account for lower levels of vitamin D, without necessarily leading to an alteration in the level of free hormone.
I
n the general population, 25-hydroxyvitamin D (25(OH)D) deficiency has been linked to hypertension. [1] [2] [3] In preeclampsia, the most severe form of pregnancy-induced hypertension, studies have consistently found alterations in calcium and vitamin D metabolism during clinical disease in late pregnancy; these include hypocalciuria 4 -7 and low serum 1,25-dihydroxyvitamin D (1,25(OH) 2 D). 8 -11 A recent nested case-control study reported lower early pregnancy levels of 25(OH)D in women who later developed preeclampsia, suggesting that 25(OH)D deficiency antedates disease onset and might contribute to its pathogenesis. 12 According to the "free hormone hypothesis," only hormones liberated from binding proteins are able to enter cells to perform biological actions. 13 Vitamin D binding protein (VDBP), abundant in the circulation, serves as the major binding protein for 25(OH)D and 1,25(OH) 2 D. Circulating vitamin D of both forms is almost entirely bound to albumin (10% to 15%) and VDBP (85% to 90%), 14, 15 which act as vitamin D reservoirs and slow its metabolism. 16 VDBP increases in high-estrogen states, such as pregnancy. 17, 18 Because measurement of total 25(OH)D is necessarily a measurement of the vitamin D/VDBP complex, alterations in VDBP levels in preeclamptic pregnancy could account for lower levels of vitamin D, without necessarily leading to an alteration in the level of free hormone.
We hypothesized that alterations in vitamin D levels reported previously in preeclamptic pregnancy may be mediated by alterations in circulating levels of VDBP. Thus, we aimed to describe and compare levels of total 25(OH)D, VDBP, and calculated free 25(OH)D in the first trimester of normotensive pregnancies and pregnancies subsequently complicated by preeclampsia.
Methods
We conducted a nested case-control study of first trimester serum 25(OH)D and VDBP levels within the Massachusetts General Hospital Obstetric Maternal Study. Massachusetts General Hospital Obstetric Maternal Study is a prospective cohort study of pregnant women, which has been described previously in detail. 19 -21 In brief, all women receiving prenatal care at Massachusetts General Hospital or an affiliate between 1998 and 2006 were eligible; 70% of eligible women approached agreed to enroll in the cohort, and enrollees had similar characteristics to those who declined. Subjects provided informed consent and were enrolled at their first prenatal visit (nϭ9930). At that time, subjects provided a serum sample, which was kept on ice for a maximum of 3 hours, then stored at Ϫ80°C for future analysis. Clinical information, including the subject's age, estimated date of confinement (from early ultrasound or self-reported last menstrual period), self-reported race, and height, was recorded. At each prenatal visit, trained care providers measured subjects' blood pressures and weights. Blood pressure was measured after Ϸ5 minutes of rest in the sitting position using an appropriate cuff size. The first and fifth Korotkoff phases were used to define systolic and diastolic blood pressures. Blood pressures, weights, and clinical information were transferred directly from the electronic medical record into the Massachusetts General Hospital Obstetric Maternal Study database, along with the results of urine dipstick testing, 24-hour urine protein measurements, glucose loading tests, glucose tolerance tests, and delivery information, including date of delivery and infant birth weight. The Partners Human Research Committee approved all of the study procedures.
All of the cases of preeclampsia were normotensive at the first prenatal visit (blood pressure: Ͻ140/90 mm Hg) and developed hypertension (systolic blood pressure Ն140 mm Hg or diastolic blood pressure Ն90 mm Hg) and proteinuria (Ն2ϩ protein on urine dipstick or Ն300 mg of proteinuria per 24 hours) after 20 weeks' gestation. A review of clinical records and International Classification of Diseases, 9th Revision, codes from billing data was conducted on subjects who met these criteria to verify the diagnosis of preeclampsia. Cases for the present study were subjects whose diagnosis of preeclampsia was confirmed, had serum samples available for analysis, and did not have gestational diabetes mellitus (according to Carpenter-Coustan criteria 22 ). Unmatched controls were chosen randomly from among women who remained normotensive throughout pregnancy, and did not have gestational diabetes mellitus 22 or give birth to small-for-gestational-age infants (birth weight less than the fifth percentile for gestational age). The sample size selected had 80% power to detect a 5-ng/mL difference in total 25(OH)D levels between cases and controls with an SD of 9.8 ng/mL. Serum samples were thawed from Ϫ80°C for analysis. 25(OH)D was measured by liquid chromatography-tandem mass spectrometry (laboratory of Dr Michael F. Holick, Boston University School of Medicine), as described previously. 23 Interassay coefficient of variation was 8.1% at 37.5 ng/mL. VDBP was measured on samples in duplicate by commercial ELISA (R&D Systems) according to the manufacturer's instructions, after diluting serum samples 1 to 4000 in Calibrator Diluent RD6-11 (R&D Systems). For this assay, the manufacturer's reported intra-assay and interassay coefficients of variation are 6.2% and 7.4%. The assay measures between 89% and 102% of exogenous VDBP added to human serum and has no significant cross-reactivity with human albumin, vitamin D3, or alpha-fetoprotein. Albumin was measured using automated clinical chemistry platform at the Massachusetts General Hospital clinical laboratory. Free levels of 25(OH)D were calculated using the following equation:
This equation, based on the binding affinities between albumin and VDBP and 25(OH)D, has been validated in a study of nonpregnant subjects where VDBP was measured by "rocket" immunoelectrophoresis and total 25(OH)D was measured by high-performance liquid chromatography. 14 The correlation coefficient between calculated free 25(OH)D and free 25(OH)D measured by centrifugal ultrafiltration was 0.925. 14 We compared baseline characteristics between cases and controls using t tests for normally distributed variables (eg, 25 [OH]D), Wilcoxon rank-sum test for non-normally distributed variables (eg, VDBP and free vitamin D), and 2 tests for categorical variables. We then conducted univariate and multivariate logistic regression analyses to determine the risk of preeclampsia depending on first trimester levels of 25(OH)D, log-transformed VDBP, and logtransformed free 25(OH)D before and after adjustment for body mass index, race, season, nulliparity, and gestational age at blood collection. We further divided subjects into tertiles, quartiles, and quintiles based on 25(OH)D levels and conducted univariate and multivariate logistic regression analyses to determine whether the risk of preeclampsia differed across these quintiles. We also conducted univariate and multivariate logistic regression analyses to determine the risk of preeclampsia in subjects who were "vitamin D deficient" (with various definitions of deficiency: 25[OH]D Ͻ15, 10, or 20 ng/mL), as compared with those who were not deficient.
Correlations were assessed using Spearman rank-order tests. We compared the levels of free and total 25(OH)D and VDBP (after natural log transformation) among subjects with different races, seasons of blood collection, and parity (nulliparous versus multiparous) using t tests or 1-way ANOVA with Holm-Sidak post hoc testing, depending on the number of groups. Data are expressed as meanϮSE or median (interquartile range), unless otherwise noted.
Results
Women who subsequently developed preeclampsia had higher body mass index and systolic and diastolic blood pressures at the first prenatal visit but were otherwise similar to controls (Table 1) . Cases were more likely to be nulliparous and nonwhite, but these differences did not reach statistical significance. 
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First trimester total 25(OH)D levels were similar in cases and controls (27.4Ϯ1.9 ng/mL versus 28.8Ϯ0.80 ng/mL; Pϭ0.435; Figure 1 Among all of the subjects, levels of total 25(OH)D were not associated with systolic or diastolic blood pressure at the time of blood collection (rϭ0.109, Pϭ0.157 and rϭ0.028, Pϭ0.718, respectively). When the analysis was restricted to white women or women without preeclampsia, total 25(OH)D levels remained unassociated with systolic or diastolic blood pressure (rϽ0.2, PϾ0.15 for each of these analyses). Similarly, VDBP and free 25(OH)D levels were not associated with first-trimester systolic or diastolic blood pressure (rϽ0.2, PϾ0.05 for all comparisons).
First trimester total 25(OH)D levels were positively correlated with first trimester VDBP levels (rϭ0.294; PϽ0.001; Figure 3 ). VDBP levels (rϭ0.218; PϽ0.004) and total 25(OH)D (rϭ0.178; PϽ0.021) levels were positively correlated with gestational age at blood collection. Both total 25(OH)D (rϭϪ0.343; PϽ0.001) and VDBP (rϭϪ0.190; Pϭ0.013) levels were inversely correlated with body mass index ( Figure 3 ). Total 25(OH)D levels were significantly lower among black non-Hispanic subjects (17.8Ϯ2.9 ng/mL; nϭ8) and Hispanic subjects (23.1Ϯ1.2 ng/mL; nϭ44) compared with white non-Hispanic subjects (31.9Ϯ0.84 ng/mL; nϭ108; PϽ0.001 for both comparisons). VDBP levels were lower in black subjects (204Ϯ68 g/mL) compared with white subjects (519Ϯ26 g/mL; PϽ0.001). VDBP levels were nonsignificantly lower in Hispanic subjects (491Ϯ44 g/mL) compared with white subjects (Pϭ0.293). Levels of calculated free 25(OH)D did not differ in black subjects or Hispanic subjects when compared with white subjects (PϾ0.05 for both comparisons). Levels of free 25(OH)D were not associated with differences in adiposity (Figure 4) .
Logistic regression analyses revealed no linear association between first trimester total 25(OH)D levels and risk of subsequent preeclampsia in univariate or multivariate analyses (Table 2 ). There was similarly no significant relationship between 25(OH)D quartile and subsequent preeclampsia ( Table 2) . Total 25(OH)D level Ͻ15 ng/mL was associated with a nonsignificantly increased risk for preeclampsia, but this relationship was attenuated after adjustment for body mass index alone or in combination with race and season ( Table 2) . First trimester VDBP levels or free 25(OH)D levels were not associated with the risk of subsequent preeclampsia (Pϭ0.666 and Pϭ0.734).
Discussion
In this nested case-control study, we found no association between first trimester total 25(OH)D and subsequent preeclampsia. Our data therefore do not support the hypothesis that first trimester 25(OH)D deficiency is linked to preeclampsia in this population. Vitamin D binding protein and calculated free levels of 25(OH)D were also not altered in the first trimester among women who later developed preeclampsia. Interestingly, we found that conditions classically associated with lower total levels of total 25(OH)D, including obesity and black race (also observed in the present study), were not associated with alterations in calculated free 25(OH)D levels.
Like previous studies, we found that first trimester blood pressures were higher in women who went on to develop preeclampsia than in women who remained normotensive. 24, 25 However, unlike Bodnar et al, 12 we did not find an independent association between first trimester 25(OH)D levels and subsequent preeclampsia. The discrepancy between our results and those of this previous study may be because of our use of first trimester measured body mass index in multivariate adjustment and differences in the populations studied.
Total 25(OH)D levels are known to be inversely correlated with adiposity, 2,26 -29 and this was true in the present study. The difference between our results and those of Bodnar et al 12 after multivariate adjustment may be partly because of differences in the way body mass index was ascertained. We used measured first trimester weights and heights to calculate body mass index rather than self-reported prepregnancy weights. When weights and heights are self-reported, biased misclassification of body mass index occurs and may lead to incomplete adjustment in multivariate analyses. 30 In addition, total 25(OH)D levels may be more likely to be associated with body mass index at the time of measurement rather than prepregnancy body mass index, because lower circulating 25(OH)D levels in obese subjects has been attributed to the deposition of vitamin D in adipose tissue. 28, 31 It is unclear whether the deficit in circulating 25(OH)D levels in the obese has physiological consequences. However, because women who gain more weight in pregnancy are at greater risk for preeclampsia, 32,33 adjustment for prepregnancy body mass index may be an inadequate method to account for the potential confounding effect of adiposity, whereas adjustment for body mass index at the time of 25(OH)D measurement may be more likely to account for this.
In contrast to Bodnar et al, 12 the present study had fewer subjects with very low levels of 25(OH)D. Of note, there was a trend toward an increased risk of preeclampsia at very low levels of 25(OH)D in univariate analyses. Accordingly, it is possible that a relationship between preeclampsia and 25(OH)D is present but only at the low extreme. Furthermore, the Massachusetts General Hospital Obstetric Maternal Study cohort has only a small proportion of black women when compared with this previous study. 12, 29 Vitamin D and calcium metabolism are known to differ by race, 34 -36 so a relationship between 25(OH)D and preeclampsia risk may be limited to black women, a hypothesis that we were not able to test in our subjects.
Past studies examining vitamin D levels in association with hypertension have not concurrently measured levels of vitamin D binding protein or calculated free vitamin D levels. [1] [2] [3] 12 Although we did not find that VDBP levels were altered in preeclampsia, we found that, like total 25(OH)D, VDBP levels were lower in black subjects and decreased with increasing adiposity. Consequently, calculated free 25(OH)D levels were not lower among black or obese women, who have been reported previously to have vitamin D deficiency. 29 To our knowledge, these associations with VDBP have not been reported previously in pregnant or nonpregnant populations. 18, [37] [38] [39] If our results are generalized to the nonpregnant population, reexamination of vitamin D deficiency in the context of VDBP levels is compelling, because such analysis may reveal that some individuals otherwise considered "vitamin D deficient" have normal free-25(OH)D levels because of a concomitant decrease in VDBP. However, the free hormone hypothesis with regard to 25(OH)D has not yet been proven or disproven in a pregnant or nonpregnant population and requires further study.
Sample size may have limited our ability to detect differences in 25(OH)D or VDBP levels between groups. However, to detect a difference with an ␣ϭ0.05 or lower in first trimester, total 25(OH)D in women with subsequent preeclampsia of the magnitude that we observed in univariate analyses, we would have required Ϸ1400 subjects each in the case and control groups. After multivariate analysis, or after restricting the analysis to nulliparous women, higher levels of total 25(OH)D actually appeared to be associated with a nonsignificantly increased risk of preeclampsia, making a true independent association between low 25(OH)D levels and preeclampsia in this cohort unlikely. We only measured 25(OH)D levels at a single time point, thus, we cannot comment on longitudinal changes in 25(OH)D levels and risk of preeclampsia. It is possible that 25(OH)D or VDBP levels measured at time points closer to the clinical onset of preeclampsia may be more closely associated with this disorder. In this regard, 25(OH)D deficiency may be a consequence of preeclampsia, such that levels are not altered until after clinical disease has developed. We also note that the index used to calculate free 25(OH)D has not been validated in pregnancy, therefore we cannot be sure that it accurately reflects the free levels of 25(OH)D in the serum. Finally, sample availability precluded measurement of 1,25(OH) 2 D in our subjects. Although 1,25(OH) 2 D is thought to be the active form of vitamin D, many tissues, including vascular smooth muscle and endothelial cells, express 1-␣ hydroxylase, thus may be able to convert circulating 25(OH)D to its active form intracellularly. 40 -42 Furthermore, the level of free 25(OH)D is highly correlated with the level of free 1,25(OH) 2 D (C.E.P., I.B., R.T., unpublished data, 2010), because this more active compound is also bound in the serum by VDBP and albumin in similar proportions. 14, 15 Future studies should examine levels of total and free 1,25(OH) 2 D along with VDBP.
Perspectives
This study does not support the hypothesis that first trimester maternal vitamin D deficiency contributes substantially to the risk of preeclampsia in this population. Alterations in VDBP levels were not associated with subsequent preeclampsia, but future research in the general population should continue to explore the relationships among VDBP, free and total vitamin D, and disease risk, given the association among VDBP, race, and body mass index in this pregnant population. Before clinical trials of vitamin D supplementation to prevent or treat preeclampsia are undertaken, ideally an association between early pregnancy or preconception vitamin D deficiency and preeclampsia should be demonstrated, after adequate adjustment for adiposity, in large prospective cohort studies.
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